Zhong J, Guo Z, Zhao J, et al. ABCB1 polymorphism predicts the toxicity and clinical outcome of lung cancer patients with taxane-based chemotherapy.,THORACIC CANCER,(11):2088-2095

Xue Yang , Chuan Huang , Rongrong Chen , Jun Zhao * Resolving Resistance to Osimertinib Therapy using Afatinib in a NSCLC Patient with an EGFR L718Q Mutation.,Clinical lung cancer,

Wang S, Chen H, Zhao J, et al. Comparative study of EGFR mutations detected in malignant pleural effusion, plasma and tumor tissue in patients with adenocarcinoma of the lung.,lung cancer,135:116-122.

Yang X, Zhuo M, Zhao J, et al. Optimal first-line treatment for advanced thymic carcinoma. Thorac Cancer. 2019 Nov;10(11):2081-2087.,THORACIC CANCER,(11):2081-2087.

Zhao J, Lin G, Zhuo M, et al. Next-generation sequencing based mutation profiling reveals heterogeneity of clinical response and resistance to osimertinib.,lung cancer,141:114-118

Zhuo M, Guan Y, Yang X ,Zhao J *et al. The Prognostic and Therapeutic Role of Genomic Subtyping by Sequencing Tumor or Cell-Free DNA in Pulmonary Large-Cell Neuroendocrine Carcinoma.,Clin Cancer Res,26(4):892-901

基于外周血分子分型的肺癌个体化诊疗体系建立及临床推广应用, 科学技术进步一等奖, 第4完成人, 教育部, 2019.1

基于外周血分子分型的肺癌个体化诊疗体系建立及临床推广应用, 科技进步奖, 第4完成人, 教育部, 2019.1

肺癌分子靶向治疗耐药机制探索

研究生招生计划

招生年度	招生专业	学位级别	学位类型	研究方向	选拔方式	操作
2024	肿瘤内科学	硕士	专业学位	临床技能训练与研究	全国统考